INSR and Alzheimer disease: Notably, AD patients have decreased insulin receptor expression and activation in the brain [43,59] and reduced CNS levels of total IRS (insulin receptor substrate) mRNAs [43,60] and PI3K and phospho-Akt levels [138,139].